Therapeutic effects elicited by the probiotic <i>Lacticaseibacillus</i> <i>rhamnosus</i> GG in children with atopic dermatitis. The results of the ProPAD trial

Laura R. Carucci(Federico II University Hospital), Roberto Berni Canani(Federico II University Hospital), Veronica Giglio(Ceinge Biotecnologie Avanzate (Italy)), Rita Nocerino(Ceinge Biotecnologie Avanzate (Italy)), Danilo Ercolini(Federico II University Hospital), Giorgio Bedogni(Ospedale "Santa Maria delle Croci" di Ravenna), Tommaso Cozzolino(Ceinge Biotecnologie Avanzate (Italy)), Vincenzo Valentino(University of Naples Federico II), Serena Coppola(University of Naples Federico II), Lorella Paparo(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Giuseppina Sequino(University of Naples Federico II), Francesca De Filippis(Federico II University Hospital), Roberto Russo(University of Naples Federico II)
Pediatric Allergy and Immunology
August 1, 2022
Cited by 65


Related Papers